These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3593904)

  • 1. Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships.
    Szpunar GJ; Albert KS; Bole GG; Dreyfus JN; Lockwood GF; Wagner JG
    Biopharm Drug Dispos; 1987; 8(3):273-83. PubMed ID: 3593904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of flurbiprofen.
    Kaiser DG; Brooks CD; Lomen PL
    Am J Med; 1986 Mar; 80(3A):10-5. PubMed ID: 3963013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition and metabolism of flurbiprofen in several species including man.
    Risdall PC; Adams SS; Crampton EL; Marchant B
    Xenobiotica; 1978 Nov; 8(11):691-703. PubMed ID: 103331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of flurbiprofen in man. II. Plasma protein binding.
    Szpunar GJ; Albert KS; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):17-30. PubMed ID: 2749000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cimetidine or ranitidine on the pharmacokinetics of flurbiprofen.
    Sullivan KM; Small RE; Rock WL; Cox SR; Willis HE
    Clin Pharm; 1986 Jul; 5(7):586-9. PubMed ID: 3742949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of oral and rectal flurbiprofen in children.
    Scaroni C; Mazzoni PL; D'Amico E; Benvenuti C; Hind ID
    Eur J Clin Pharmacol; 1984; 27(3):367-9. PubMed ID: 6510467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the ocular and systemic disposition of flurbiprofen: the effect of altered protein dynamics at steady state.
    Tang-Liu DD; Liu S
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):387-97. PubMed ID: 3681666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of flurbiprofen to plasma proteins.
    Aarons L; Khan AZ; Grennan DM; Alam-Siddiqi M
    J Pharm Pharmacol; 1985 Sep; 37(9):644-6. PubMed ID: 2867185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function.
    Cefali EA; Poynor WJ; Sica D; Cox S
    J Clin Pharmacol; 1991 Sep; 31(9):808-14. PubMed ID: 1804864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.
    Chalmers TM; Glass RC; Risdall PC
    Curr Med Res Opin; 1977; 5(1):17-20. PubMed ID: 303167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding of flurbiprofen: enantioselectivity and influence of pathophysiological status.
    Knadler MP; Brater DC; Hall SD
    J Pharmacol Exp Ther; 1989 May; 249(2):378-85. PubMed ID: 2724130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypes.
    Lee CR; Pieper JA; Frye RF; Hinderliter AL; Blaisdell JA; Goldstein JA
    Eur J Clin Pharmacol; 2003 Apr; 58(12):791-4. PubMed ID: 12698304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some pharmacokinetic data of flurbiprofen in the goat.
    Van Miert AS; Van Gogh H; Hind ID; Bresloff P
    J Vet Pharmacol Ther; 1983 Dec; 6(4):315-7. PubMed ID: 6668643
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships.
    Lockwood GF; Albert KS; Gillespie WR; Bole GG; Harkcom TM; Szpunar GJ; Wagner JG
    Clin Pharmacol Ther; 1983 Jul; 34(1):97-103. PubMed ID: 6861443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time.
    Cardoe N; de-Silva M; Glass RC; Risdall PC
    Curr Med Res Opin; 1977; 5(1):21-5. PubMed ID: 913119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of flurbiprofen and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1995 Feb; 28(2):100-14. PubMed ID: 7736686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective pharmacokinetics of flurbiprofen in humans and rats.
    Jamali F; Berry BW; Tehrani MR; Russell AS
    J Pharm Sci; 1988 Aug; 77(8):666-9. PubMed ID: 3210154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone.
    Akhter SA; Barry BW
    J Pharm Pharmacol; 1985 Jan; 37(1):27-37. PubMed ID: 2858524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of liver and renal disease on stereoselective serum binding of flurbiprofen.
    Blouin R; Chaudhary I; Nishihara K; Cox S
    Br J Clin Pharmacol; 1993 Jan; 35(1):62-4. PubMed ID: 8448071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.